TWo medicines for Covid-19 enter Phase III Clinical trials
New Delhi, Oct. 21 -- At least two existing medicines that were repurposed for the treatment of Covid-19 have entered Phase III clinical trials in India as the world waits for a vaccine to protect people against the viral disease or a drug that can act specifically against it....
To read the full article or to get the complete feed from this publication, please
Contact Us.